Skip to main content
OpenTrials
Completed

NCT Number: NCT07528573

HIV Prevention and Care Engagement in Nepal

This intervention focuses on increasing HIV testing, HIV medication adherence and reducing intersectional stigma. Our Sweekar intervention will implement 5 months of group-based activities to address the social stigma and HIV prevention and care needs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

BDS

Kathmandu, Nepal

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 18 years old or older
  • identify as transgender, hijra, Meti, third gender or anything other than a gender typically associated with a male assigned sex at birth
  • live in the Terai highway district Madesh Province
  • Maithili- or Nepali-speaking
  • Willing to be part of the study for 6 months
  • Willing to travel, if needed, to participate in group sessions

For those who test HIV negative:

  • Willing to self-test
  • Have or willing to have a mobile phone
  • Not HIV tested within the last 3 months

For those who test HIV positive:

(a) screen positive for HIV treatment non-adherence by self-report

Exclusion criteria

  • Cannot or will not consent to the research,
  • Female sex assigned at birth,
  • Self-identify as a man
  • Do not speak Maithli or Nepali
  • Age under 18 -

Treatment and study plan

Sweekar intervention

Behavioral

The HIV prevention components focus on HIV education and use of HIV self-testing kits to increase frequency of HIV testing. The HIV care component is information and linkage to HIV treatment information and adherence support.

Primary outcomes

  1. HIV testing Self-testing kits

    Time frame: At baseline and at 3 months

    Number of HIV self tests kits used at home or at a hospital or clinic

  2. HIV testing frequency

    Time frame: Baseline, 3 months and 6 months

    HIV testing; Number of times received HIV testing using clinic or resources that is not HIV self-testing kits

  3. HIV treatment engagement

    Time frame: At baseline, 3 months and 6 months

    Self-reported Wilson's Medication Scale to assess adherence patterns.

Sponsors and collaborators

Lead sponsor

Public Health Foundation Enterprises, Inc.

Other

Collaborators

  • Fogarty International Center of the National Institute of Health

Registry information

Official study title

Sweekar - Multi-level Intersectional Stigma Reduction Intervention to Increase HIV Testing and Care Engagement in Nepal

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 14, 2026
Registry last updated
Apr 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.